Proteomics Market to Register Robust CAGR of 17.12% through 2026
Increase in research activities across
the globe along with rising government funding to drive the growth of global proteomics
market.
According to TechSci Research report, “Global Proteomics Market By Application (Clinical
Diagnostic, Drug Discovery, Diagnostic Biomarker Discovery, Others), By
Indication (Oncology, Infectious Disease, Respiratory, Cardiology, Others), By Technology
(Conventional, Advanced, Quantitative, High-throughput, Bioinformatic Analysis),
By Type (Expression, Functional, Structural, Computational), By Product (Reagents
and Assays, Instruments, Software & Services), By End-User (Pharmaceutical
and Biotechnology Companies, Research Institutes, CROs), By Region, Competition, Forecast & Opportunities,
2026F”, global proteomics market
is expected to grow at an impressive CAGR of 17.12% during the forecast period
and was valued at USD24.26 billion in 2020. Growing application of proteomics
in discovery of new drugs is one of the major factor accounting for the growth of global proteomics
market. Moreover, use of proteomics during the development of personalized medicines
is further expected to bode well for the growth of global proteomics through
the forecast years. In addition to this, rising awareness pertaining to the
benefits of personalized medicines, is leading to increased expense in research
activities for the development of proteomics by the leading companies as well
as government organizations which in turn is expected to positively influence
the growth of global proteomics market over the years to come. Also, identification
of potential new drugs for the treatment of several diseases such as genetic
disorders, birth disorders, among others is making headway for the growth of
global proteomics market across the globe. However, there are some factors that
can act as major impediments to the growth of global proteomics market through
2026 such as lack of skilled professionals and high cost of instruments.
Browse 207
Figures spread through 110 Pages and an in-depth TOC
on "Global Proteomics Market"
https://www.techsciresearch.com/report/proteomics-market/4559.html
Global proteomics market can be segmented based
on application, indication, technology, type, product, end-user, company and region. Considering the end-user, the market
is fragmented into pharmaceutical and biotechnology companies, research
institutes and, CROs. The pharmaceutical and biotechnology companies segment dominated
the global proteomics market in terms of largest market size until 2020. Additionally,
requirement for protein therapeutics, including hormones, vaccines, monoclonal
antibodies, among others is further aiding the growth of the segment through 2026.
In terms of product, the market is fragmented into reagents and assays, instruments,
software & services. Out of which, the reagents and assays segment is
dominating the market and will maintain its lead during the forecast period,
which can be accredited to their routine adoption in proteomics protocols.
Thermo Fisher Scientific, Inc., Agilent
Technologies, Inc., Waters Corporation, Bio-Rad Laboratories, Inc., Danaher
Corporation (SCIEX), GE Healthcare, Inc., PerkinElmer, Inc., Becton, Dickinson
and Company, Illumina, Inc., Biocon Limited, Qiagen N.V., Bruker Corporation,
Luminex Corporation, Evotec SE, Horiba, Ltd., Creative Proteomics, Promega
Corporation, CellCarta Precision Medicine, Inc., Bioproximity LLC, Applied
Biomics, Inc., are among others are
the leading players operating in global proteomics market. The players are adopting several growth strategies to stay
competitive in the global proteomics market. Other
competitive strategies include mergers & acquisitions to diverse their
product portfolio in order to strengthen their market position.
Download Sample Report @ https://www.techsciresearch.com/sample-report.aspx?cid=4559
Customers can also request for 10% free
customization on this report.
“North
America is forecast to dominate the global proteomics market during the next 5
years on account of presence of major market players in the region. Moreover, growing
expenditure on the development of structure-based drug designs coupled with increasing
research in the fields of proteomics is also expected to contribute to the
growing trend. Furthermore, Asia-Pacific is forecast to register high growth
through 2026 due to growing biotechnology research, and rising awareness on
personalized therapeutics in the region. Furthermore, need for high-quality
research tools for data reproducibility is further expected to boost the market
growth in Asia-Pacific region until 2026.”, said Mr. Karan Chechi, Research
Director with TechSci Research, a research based global management consulting
firm.
“Global
Proteomics Market By Application (Clinical Diagnostic, Drug Discovery,
Diagnostic Biomarker Discovery, Others), By Indication (Oncology, Infectious
Disease, Respiratory, Cardiology, Others), By Technology (Conventional,
Advanced, Quantitative, High-throughput, Bioinformatic Analysis), By Type
(Expression, Functional, Structural, Computational), By Product (Reagents and
Assays, Instruments, Software & Services), By End-User (Pharmaceutical and
Biotechnology Companies, Research Institutes, CROs), By Region, Competition, Forecast & Opportunities,
2026F” has evaluated the
future growth potential of global proteomics market and provides statistics
& information on market size, structure and future market growth. The
report intends to provide cutting-edge market intelligence and help decision
makers take sound investment decisions. Besides, the report also identifies and
analyzes the emerging trends along with essential drivers, challenges and
opportunities in global proteomics market.
Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York – 10017
Tel:
+1-646-360-1656
Email: [email protected]
Website: https://www.techsciresearch.com/